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Background: The role of flagellin glycosylation 
is not well understood.  
Results: The Burkholderia cenocepacia 
flagellin is glycosylated on at least ten different 
sites. 
Conclusion: The presence of glycan in flagellin 
significantly impaired the inflammatory 
response of epithelial cells. 
Significance: Flagellin glycosylation reduces 
recognition of flagellin by host TLR5, providing 
an evasive strategy to infecting bacteria. 
 
ABSTRACT 
Burkholderia cenocepacia is an opportunistic 
pathogen threatening patients with cystic 
fibrosis. Flagella are required for biofilm 
formation, as well as adhesion to and invasion 
of epithelial cells. Recognition of flagellin via 
the Toll-like receptor 5 (TLR5) contributes to 
exacerbate B. cenocepacia-induced lung 
epithelial inflammatory responses. In this 
study, we report that B. cenocepacia flagellin 
is glycosylated on at least ten different sites 
with a single sugar, 4,6-dideoxy-4-(3-
hydroxybutanoylamino)-D-glucose [D-
Qui4N(3HOBut)]. We have identified key 
genes that are required for flagellin 
glycosylation including a predicted 
glycosyltransferase gene that is linked to the 
flagellin biosynthesis cluster, and a putative 
acetyltransferase gene located within the O-
antigen lipopolysaccharide cluster. Another 
O-antigen cluster gene, rmlB, which is 
required for flagellin glycan and O-antigen 
biosynthesis, was essential for bacterial 
viability, uncovering a novel target against 
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Burkholderia infections. Using glycosylated 
and non-glycosylated purified flagellin and a 
cell reporter system to assess TLR5-mediated 
responses, we also show that the presence of 
glycan in flagellin significantly impair the 
inflammatory response of epithelial cells. We 
therefore suggest that flagellin glycosylation 
reduces recognition of flagellin by host TLR5, 
providing an evasive strategy to infecting 
bacteria.  
 
 Burkholderia cenocepacia is a Gram-
negative bacterium belonging to the 
Burkholderia cepacia complex (Bcc). This 
group of opportunistic pathogens poses a health 
threat to patients with cystic fibrosis (1,2). 
Chronic airway infection of these patients with 
the Bcc bacteria, particularly B. cenocepacia, 
accelerates the decay of lung function and in 
some cases leads to a lethal necrotizing 
pneumonia known as “cepacia syndrome” (3). 
Bcc infections have also been reported in 
nosocomial outbreaks not related to cystic 
fibrosis (4-7). Together with B. multivorans, B. 
cenocepacia accounts for the majority of Bcc 
infections in cystic fibrosis patients (8,9). B. 
cenocepacia encompasses at least four 
phylogenetic lineages, IIIA to IIID, but most of 
the CF isolates belong to lineage IIIA and IIIB 
(10,11). The clonal lineage ET12 belongs to the 
IIIA group and these bacteria were responsible 
for most of the deaths related to “cepacia 
syndrome” in early 1980s (3,12,13). 
 B. cenocepacia K56-2 is an ET12 strain that 
carries various virulence factors including 
lipopolysaccharide (LPS) and flagella. The LPS 
from K56-2 has been intensively studied in our 
laboratory (14-18) and consists of lipid A, core 
oligosaccharide, and polymeric O antigen (19). 
The K56-2 O antigen is a polymer of a 
trisaccharide-repeating unit containing rhamnose 
and two N-acetylgalactosamine residues (15). In 
general, LPS is a potent proinflammatory 
molecule, and the K56-2 O antigen influences 
phagocytosis by human macrophages and 
interferes with bacterial adherence to bronchial 
epithelial cells (18,20). 
 Flagella are organelles for bacterial motility, 
but they are also involved in pathogenicity (21) 
such as adhesion to and invasion of epithelial 
cells, and biofilm formation (22-26). Flagella 
consist of a basal body, flagellar hook, and a 
filament built of flagellin monomers, which are 
specifically recognized by the innate immune 
system via the Toll-like receptor 5 (TLR5) 
(26,27). Toll-like receptors are membrane-bound 
pattern-recognition receptors in epithelial and 
immune cells, which play an essential role in 
initiating innate immune responses (28). TLRs 
recognize pathogen-derived microbial molecules 
(pathogen-associated molecular patterns) like 
LPS (TLR4) or flagellin (TLR5). Engagement of 
TLR by its specific ligand initiates an 
intracellular signaling cascade leading to the 
activation of nuclear factor κB (NF-κB) and 
members of the mitogen-activated protein 
(MAP) kinase family. These signaling pathways 
subsequently activate transcription of pro-
inflammatory cytokines like interleukin-1 (IL-1), 
IL-6, IL-8, and tumor necrosis factor α (TNF-α). 
The TLR5 signalling pathway plays a pivotal 
role in exacerbating lung inflammation in cystic 
fibrosis (29) and it is responsible for B. 
cenocepacia-induced lung epithelial 
inflammatory response (30). Furthermore, a 
mutation leading to reduced activating capacity 
of the TLR5 was associated with reduced organ 
failure and improved survival in patients 
infected with B. pseudomallei, another important 
pathogen of the genus Burkholderia (31), 
underscoring the critical role of TLR5 and its 
ligand in human infection. 
 B. cenocepacia strains produce two types of 
flagellin, type I and II, distinguished by the 
molecular size of the protein and restriction 
fragment length polymorphism analyses (32). 
Flagellin in B. cenocepacia K56-2 belongs to 
type II and these bacteria carry a single, long 
polar flagellum that contributes to virulence in a 
mouse infection model and induces host immune 
responses via TLR5 (26). B. pseudomallei and 
B. thailandensis produce glycosylated flagellin 
(33), but the glycosylation status of flagellin in 
B. cenocepacia is unknown. In this work, we 
report that B. cenocepacia flagellin filaments are 
posttranslationally modified by glycosylation at 
multiple sites with a single glycan residue and 
identify the key genes responsible for this 
modification. We also demonstrate that flagellin 
glycosylation reduces the ability of this protein 
to trigger TLR5-mediated inflammatory 
responses in epithelial cells. 
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EXPERIMENTAL PROCEDURES 
 
 Strains and Chemicals–The strains used in 
this study are listed in Table 1. Bacteria were 
grown either on 1.5% agar plates or in LB Broth 
(Lennox) at 37°C. When required, antibiotics 
were added as follows: trimethoprim, 50 µg ml-1 
for E. coli and 100 µg ml-1 for B. cenocepacia; 
tetracycline, 20 µg ml-1 for E. coli and 100 µg 
ml-1 for B. cenocepacia; kanamycin, 40 µg ml-1 
for E. coli; chloramphenicol, 30 µg ml-1 for E. 
coli and 150 µg ml-1 for B. cenocepacia. 
Ampicillin at 200 µg ml-1 was used during 
triparental mating to selectively eliminate donor 
and helper E. coli strains. When required, 
rhamnose was added to a final concentration of 
0.4% (w/v). Sucrose plates for the final curing of 
deletion mutants were prepared with 10 g l-1 of 
tryptone, 5 g l-1 of yeast extract and 50 g l-1 of 
sucrose in 1.5% agar. Antibiotics and chemicals 
were purchased from Sigma Chemicals (St 
Louis, MO, USA). Growth media were 
purchased from Becton, Dickinson and 
Company (Sparks, MD, USA). Restriction 
enzymes, Antarctic phosphatase and T4 ligase 
were purchased from New England Biolabs 
(Ipswich, MA, USA). HEK293-TLR5 cells 
expressing human TLR5 were purchased from 
Invivogen (San Diego, USA) and p-P65, p-ERK, 
ERK, p-P38, P38, p-JNK and JNK antibodies 
from Cell Signalling (Danvers, MA, USA). P65 
was purchased from Santa Cruz Biotechnology 
(Dallas, TX, USA) and β-actin antibody from 
Sigma-Aldrich (St Louis, MO, USA). 
 Isolation of Flagellin–Flagella were isolated 
as in Brett et al (34) with some modifications. 
Briefly, bacteria were grown for 18 h in 400 ml 
LB with antibiotics and/or rhamnose as required, 
centrifuged, and the bacterial pellets frozen at -
20°C overnight. Thawed pellets were next 
resuspended in 20 ml PBS and flagella were 
sheared off with a homogenizer (low speed 
setting for 4 min on ice). Cell debris was 
removed by centrifugation (6,000 x g, 10 min, 
4°C) and flagella were precipitated overnight 
from the supernatant with ammonium sulphate 
(end concentration 5%). The precipitate was 
centrifuged (12,000 x g, 30 min, 4°C) and the 
supernatant discarded. The pellet, containing 
flagella, was dissolved in 750 µl PBS of which 
250 µl were stored at -20°C for SDS PAGE 
analysis (crude flagellar filaments fraction) and 
the remaining 500 µl were centrifuged again 
(16,900 x g, 10 min, 4°C). Flagellar filaments in 
the sediment were solubilized with 8 M urea; 
insoluble debris was removed by centrifugation 
(10,000 x g, 1 min) and the solubilized flagellin 
was desalted on a HiTrap ÄKTA FPLC column 
(GE Healthcare) using either 25 mM ammonium 
bicarbonate (prior to structural analyses) or PBS 
(for biological tests) as eluents. Soluble and 
purified flagellin was either stored at -20°C or 
lyophilized.  
 SDS-PAGE and Western Blot–The purity 
and the molecular mass of flagellin were 
assessed in 14% SDS-PAGE gels stained with 
PageBlue protein staining solution (Thermo 
Scientific). BioRad Precision Plus Dual Color 
Protein Standard was used as a molecular weight 
marker. To visualize glycosylated proteins, the 
Pro-Q Emerald glycoprotein stain kit was used 
accordingly to the manufacturer’s manual 
(Molecular Probes). Flagellin was detected on 
Western blots with primary polyclonal antibody 
RFFL/ARP42986_P050 
(http://www.avivasysbio.com/rffl-antibody-
middle-region-arp42986-p050.html) provided by 
AVIVA Systems Biology;	  San Diego, USA and 
with secondary goat anti-rabbit IgG-HRP 
secondary antibody. The blots were developed 
with Western Lightning ECL Pro (Perkin-
Elmer).  
 Mass Spectrometry and Enzymatic 
Digestion–Flagellin was in-gel digested with 
trypsin, chymotrypsin, AspN and a mixture of 
AspN and trypsin. LC MS/MS mass 
spectrometry analyses were performed on a 
Waters QTof Global mass spectrometer 
equipped with a Z-spray (ESI) source and run in 
positive ion mode (the instrument was run in 
DDA mode) in combination with a Waters 
nanoAcquity UPLC, and the results were 
confirmed with a Thermo Scientific Orbitrap 
Elite MS (LC-MS/MS). The Peaks software 
(Bioinformatics Solutions Inc.) was used to 
analyse the digested samples. Waters QTof 
Micro with Waters MassLynx 4.1 was used for 
whole protein analyses. Flagellin was analysed 
as an intact protein in 25 mM ammonium 
bicarbonate. Lyophilized, digested samples were 
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reconstituted in 20 µl of 0.2% formic acid in 
water and 10 µl were injected.  
 Chemical Deglycosylation of Flagellin–
Desalted and lyophilized protein (1.5 mg) was 
chemically deglycosylated by 
trifluoromethanesulfonic acid (TFMS) (35). 
Briefly, 100 µl of a 10% toluene/TFMS mixture 
was slowly added to the sample in a glass vial 
placed in a dry ice/ethanol bath. After 2 h, the 
mixture was carefully neutralized with 300 µl 
pyridine solution (pyridine: methanol: water at a 
ratio of 3:1:1 v:v:v) for 5 min in a dry 
ice/ethanol bath, and the sample was transferred 
to wet ice for another 15 min. The mixture was 
transferred into a plastic 1.5 ml vial and 400 µl 
of 25 mM ammonium bicarbonate was added to 
precipitate the deglycosylated flagellin. After 
centrifugation (16,900 x g, 10 min), the 
supernatant was discarded and the pellet 
dissolved in 8 M urea. Further desalting in 25 
mM ammonium bicarbonate was performed on a 
HiTrap column as described above and the 
sample was used directly for MS analysis. 
 GC/MS Analyses and β-Elimination–
Methanolysis was used to analyze the glycan 
moiety of flagellin. Briefly, 400 µg of the 
lyophilized sample was treated with 0.5 M 
methanolic HCl (weak methanolysis), 
peracetylated and an aliquot was used to record 
GC/MS spectra. Next, the same sample was 
treated with 2 M methanolic HCl (strong 
methanolysis), peracetylated and analyzed again. 
To determine the character of bound glycosyl 
residue, another 400 µg of lyophilized flagellin 
was used for β-elimination. Briefly, 400 µg of 
lyophilized sample were treated with 0.1 M 
NaOH containing 0.8 M NaBH4 for 8 h at 37°C 
in the dark. Next, the mixture was dried under 
nitrogen, peracetylated and analyzed. To 
confirm the conformation of the sugar, ions 
detected in GC/MS spectra from B. cenocepacia 
FliC were compared with GC/MS of the O 
antigen sample from Providencia stuartii O43 
(kindly provided by J. Knirel and O. 
Ovchinnikova). The D-configuration of the sugar 
was determined by octanolysis (36). Mass 
spectrometric measurements were performed 
with Agilent Technologies 5975 inert XL MSD 
equipped with split/splitless injector system with 
EI under autotune conditions at 70 eV. 
 General Molecular Techniques and Genetic 
Manipulation of B. cenocepacia–Plasmid vectors 
and primers are listed in Table 1 and Table 2, 
respectively. DNA manipulations and cloning 
were performed as previously described (37). 
PCR reactions were performed with HotStar 
HiFidelity DNA Polymerase (Qiagen). Plasmid 
and genomic DNA were isolated using QiaPrep 
Spin kit and DNeasy Blood and Tissue kit 
(Qiagen), respectively. PCR products were 
purified using a QIAquick PCR purification kit 
or a QIAquick gel extraction kit (Qiagen). 
Freshly prepared chemically competent E. coli 
GT115 cells were transformed by the calcium 
chloride method. Plasmids were mobilized into 
B. cenocepacia by triparental mating (14,38). 
 Cloning of B. cenocepacia K56-2 fliC–The 
fliC gene (BCAL0114) was amplified from B. 
cenocepacia K56-2 genomic DNA with the 
primer pair 6093/6094 and sequenced at the 
Core Molecular Biology Facility, York 
University, Toronto, Canada. The B. 
cenocepacia K56-2 fliC sequence was submitted 
to GenBank and is available under submission 
number KC763156. 
 Construction of Mutants in B. cenocepacia–
Unmarked deletion mutants were constructed as 
described previously (14,38). Briefly, the target 
genes were deleted by allelic exchange using the 
pGPI-SceI-2 plasmid containing the 
corresponding upstream and downstream 
fragments. The resulting deletion plasmids were 
introduced into B. cenocepacia by triparental 
mating. Upstream fragments for deletion of the 
vioA homologue in the O-antigen cluster 
(BCAL3129), flmQ (BCAL0111), the vioA 
homologue in the fliC cluster (BCAL0110), the 
rmlD homologue (BCAS0105), the O-antigen 
cluster between wbiI and wzm (BCAL3119-
BCAL3131), and wbxC/wbxD (BCAL3123-
BCAL3124) (15) were amplified with primer 
pairs 6165/6166, 5235/5236, L0110 US 
XbaI/L0110 US NotI, 5922/5923, 5852/5853, 
and L3123 US BglII/L3123 US NotI, and 
downstream fragments by 6167/6168, 
5237/5238, L0110 DS NotI/L0110 DS BglII, 
5924/5925, 5888/5889, Q38/Q39, respectively 
(Table 2). The insertional inactivation of rmlD 
(BCAL3132) was achieved by cloning ~ 300 bp 
internal fragments from BCAL3132 (amplified 
using primers pair 5685/5686; Table 2) into 
5	  
	  
pGPΩTp.  The resulting mutagenesis plasmid 
pGPΩTp/rmlD was mobilized into B. 
cenocepacia (39). Conditional mutants in rmlB 
(BCAL3135), rmlC (BCAL3133), rmlD 
(BCAL3132) and flmQ (BCAL0111) were 
constructed using pSC200 (17). The primers 
used to amplify DNA fragments were as 
follows: 6021/6022 (rmlB), Q92/Q91 (rmlC), 
6023/6024 (rmlD) and Q89/Q90 (flmQ; Table 
2). Each amplicon contained the NdeI restriction 
site in the starting codon of each gene to 
facilitate cloning into pSC200. 
 Rhamnose Depletion Assays–Conditional 
mutants were grown overnight in 5 ml LB with 
trimethoprim (100 µg ml-1) and 0.4% rhamnose. 
The next day, 1 ml of each strain was 
centrifuged and washed thrice with LB without 
rhamnose. The optical density (OD600) was 
adjusted to 1.0 in LB without rhamnose and 3 µl 
of each dilution of 10-1 to 10-6 were incubated at 
37°C on LB agar with trimethoprim with or 
without 0.4% rhamnose for 24 h. The 
essentiality of each respective gene was also 
assessed in broth. For this, overnight cultures 
grown in 5 ml LB with trimethoprim (100 µg 
ml-1) and 0.4% rhamnose were centrifuged and 
washed thrice in LB without rhamnose. Each 
strain was diluted to OD600 0.03 in 
LB/trimethoprim with or without rhamnose and 
triplicates of 300 µl were incubated for 4 h in 
honeycomb plates at 37°C with shaking using a 
Bioscreen (Oy Growth Curves, Finland). Next, 3 
µl of each dilution were transferred to fresh 
medium with or without rhamnose and 
incubated for additional 19 h. The OD600 was 
measured every 30 min. Strains XOA10 (B. 
cenocepacia K56-2 pSC200/BCAL1928; non-
lethal conditional mutant) and XOA11 (B. 
cenocepacia K56-2 pSC200/arnT; lethal 
mutation) were used as controls (17). 
 Complementation experiments–Plasmid 
pIN62 (encoding chloramphenicol resistance; 
(40)) was used to complement BCAL3123, 
which was cloned from B. cenocepacia K56-2 
genomic DNA using the L3123 XbaI/L3123 
NdeI primer pair (Table 2). The plasmid and 
PCR product were digested with XbaI and NdeI 
at 37°C for 16 h. The digested plasmid DNA 
was subsequently dephosphorylated using 
Antarctic phosphatase (37°C, 30 min), which 
was then deactivated at 65°C (2 min). Ligation 
was performed at 16°C for 16 h using T4 DNA 
ligase. Transformation and triparental mating 
were performed as described previously (see text 
above). The resulting plasmid 
pIN62/BCAL3123 (as confirmed by sequencing) 
was introduced into the appropriate B. 
cenocepacia strains via triparental mating. 
 Whole Cell Lysates and LPS Staining–To 
determine the presence of O antigen, whole cell 
lysates were prepared and resolved on 14% 
SDS-polyacrylamide gels and LPS was 
visualized by silver staining as described 
previously (41), except that instead of citric acid, 
a mixture of 2.5% sodium carbonate (wt/v) with 
0.05% formaldehyde (v/v) in water heated to 
60°C was used as developing solution. 
 Motility Assays and Biofilm Formation–
Bacterial motility was analyzed on soft agar 
plates (1% Bacto tryptone in 0.3% agar). The 
OD600 of overnight cultures was adjusted to 1.0 
and 2 µl of culture were inoculated in the centre 
of agar plate. The growth zone diameter was 
measured after 24h of incubation at 37°C. 
Biofilm mass was quantified by the crystal violet 
protocol as described previously (42). 
 Biological Assays–Flagellin from B. 
cenocepacia parental strain and the BCAL0111 
deletion mutant was purified in PBS as 
described above. The concentration of FliC was 
confirmed densitometrically. THP1 cells or 
HEK293-TLR5 cells were seeded (2 x 105 cells 
ml-1; 2ml) in 12-well plates and stimulated with 
the indicated concentrations of WT and non-
glycosylated flagellin for 24 h. Conditioned 
medium was then measured for levels of TNF-α, 
IL-6, IL-8 and IL-1β (DuoSet kits; R&D 
Systems) according to the manufacturer’s 
protocol. For luciferase reporter assays, HEK293 
TLR5 cells were seeded (1.5 × 105 cells ml-1; 
200 µl) in 96-well plates and transfected with 
constructs encoding NFκB-regulated firefly 
luciferase (80 ng) and the TK Renilla luciferase 
reporter construct (phRL-TK; 20 ng; Promega 
Biosciences). Cells were treated as indicated and 
cell lysates assayed for firefly luciferase activity 
and normalized for transfection efficiency using 
TK Renilla luciferase activity. Cell extracts were 
also assayed for phosphorylated and total levels 
of p65 and p38, JNK and ERK MAP kinases by 
Western blotting.  
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RESULTS 
 
 B. cenocepacia Flagellin is Glycosylated 
with 4,6-dideoxy-4-(3-hydroxybutanoylamino)-
D-glucose–Flagella were sheared off B. 
cenocepacia cells and solubilized with 8 M urea, 
as described in Experimental Procedures (Fig. 
1A). Mass spectrometric analyses of tryptic 
digests confirmed the identity of the flagellin 
monomer (FliC). Further MS analyses of native 
FliC revealed one major molecular ion at 40,836 
m/z and minor ions at 40,605 m/z, 40,374 m/z, 
40,143 m/z, and 41,067 m/z (Fig. 2A). These 
masses were compared with the theoretical mass 
of FliC from B. cenocepacia J2315, which is 
38,779.79 Da. Strains J2315 and K56-2 belong 
to the ET12 clone, but J2315 was the only ET12 
strain sequenced at the time of these experiments 
(43). Thus, the observed mass of the major 
molecular ion was 2,057 Da larger than expected 
from the theoretical amino acid sequence. 
Moreover, the molecular ions differed from each 
other by 231 m/z, suggesting the presence of at 
least five modifications. In SDS-PAGE gels, 
FliC was visualized by Coomassie blue staining 
and also reacted with Pro-Q Emerald 
glycoprotein stain, suggesting that the observed 
modifications were due to glycosylation. FliC 
was also detected on Western blot with the 
primary antibody RFFL/ARP42986_P050 (Fig. 
1B-C). 
 To accurately determine the molecular mass 
of FliC, purified flagellin was chemically 
deglycosylated, as indicated in Experimental 
Procedures. The deglycosylation method was 
optimized to specifically cleave glycosidic 
bonds without damaging the peptide backbone 
(35). The MS analysis of the deglycosylated 
protein showed a single molecular ion of 
38,756.90 m/z (Fig. 2B). This result provided 
additional evidence that FliC was modified by a 
glycan. Furthermore, MS of the tryptic digest 
confirmed the identity of the deglycosylated 
protein as FliC, except that it was 23 Da smaller 
than expected from the theoretical mass of the 
J2315 FliC (38,779.79 Da). This suggested that 
FliC proteins from K56-2 and J2315 were not 
completely identical. DNA sequencing of the 
fliC (BCAL0114) gene from K56-2 revealed a 
single C to A substitution at 1072 bp, resulting 
in a histidine to asparagine replacement at 
position 358 in the K56-2 FliC (H358N) giving 
a 23 Da difference in molecular mass. The 
difference in mass between native and 
chemically deglycosylated FliC was also 
reflected in SDS-PAGE analyses by Coomassie 
blue staining (Fig. 1D). However, 
deglycosylated FliC still reacted with Pro-Q 
Emerald, indicating that this stain was not 
specific for the B. cenocepacia FliC glycan. 
 Since trypsin digestion alone did not provide 
sufficient peptide coverage spanning the entire 
FliC protein, additional digestions were 
performed with chymotrypsin, AspN, and a 
mixture of AspN and trypsin. Mass spectra were 
recorded for all four digested samples separately 
and the combined data were analysed, giving 
100% sequence coverage. This strategy allowed 
us to identify ions matching the peptides with 
one or two 231 m/z modifications (Table 3). 
Thus, the localization of single modifications 
was assigned to peptides 159DLSQSMSAAK168, 
177GQTVGTVTGLSLDNNGAYTGSGATITAI
NVLSDGK211, and 
287DISTVSGANVAMVSIDNALQTVNNVQA
ALGAAQNR321, while peptides 
212GGYTFTDQNGGAISQTVAQSVFGAN233, 
234GANATTGTGTAVGNLTLQ251 and 
252SGATGAGTSAAQQTAITNAIAQINAVNK
PATLVSNL286 carried two modifications. From 
these combined results, we could clearly identify 
nine out of ten possible modification sites (as 
determined by MS of the entire FliC (Figs. 2A 
and 2D, and Table 3). The exact position of the 
modifications in each peptide was not 
determined. 
 To identify the nature of the FliC glycan, 
flagellin was analysed by GC/MS. Combined 
data collected from GC/MS spectra after weak 
and strong methanolysis identified a 4,6-
dideoxy-4-(3-hydroxybutanoylamino)-hexose. 
Comparison with GC/MS spectra obtained after 
similar treatment of Providencia stuartii O43 O-
antigen samples (44), confirmed that the sugar 
possessed the gluco configuration, representing 
viosamine with 3-hydroxybutyric acid 
substituting amino group at C4, referred to as D-
Qui4N(3HOBut) (Fig. 3 and 4). We used β-
elimination to establish the character of the 
glycosidic bond between glycan and the FliC 
peptide backbone. The β-elimination releases 
glycans that form O-glycosidic bonds with 
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serine or threonine, leaving N-glycosidic bonds 
intact. D-Qui4N(3HOBut) was the only sugar 
identified by GC/MS analysis of the sample after 
β-elimination (Fig. 4), demonstrating that B. 
cenocepacia FliC was O-glycosylated. The 
structure of the glycan was also consistent with 
the measured mass difference of 231 Da (theor. 
MW 249.1212 - H2O = 231.1106; Fig. 3). 
 Identification of the Genes Involved in FliC 
Glycosylation–The flagellin gene fliC 
(BCAL0114) lies upstream of fliD (BCAL0113), 
fliT (BCAL0112), BCAL0111 and BCAL0110. 
The fliD and fliT encode the flagellar hook 
associated protein and a flagellar chaperone, 
respectively. BCAL0110 encodes a putative 
VioA aminotransferase homologue 
(aminotransferase involved in synthesis of 
Qui4N; Fig. 5A), while BCAL0111 encodes a 
predicted protein with homology to the group 1 
superfamily of glycosyltransferases and also 
containing four tetratricopeptide repeats. In 
silico analysis of BCAL0111 with HHpred 
(http://toolkit.tuebingen.mpg.de/hhpred) 
revealed a C-terminal domain 360 amino acids 
that is structurally homologous to several well 
characterized glycosyltransferases including the 
PimB mannosyltransferase from 
Corynebacterium glutamicum (45), the human 
UDP-N-acetylglucosamine-peptide N-
acetylglucosamine transferase (46), and WaaG 
lipid A-core biosynthesis glycosyltransferase 
(47). To investigate whether BCAL0111 plays a 
role in FliC glycosylation, we constructed a 
ΔBCAL0111 deletion mutant and analysed its 
purified flagellin. Coomassie stained SDS-
PAGE of FliC from ΔBCAL0111 showed a 
downshift in apparent molecular size (Fig. 1C), 
which was also evident by Western blotting with 
the RFFL/ARP42986_P050 antibody (Fig. 1B). 
Together, these results demonstrated that 
flagellin biosynthesis can proceed in the absence 
of glycosylation and that the antibody was 
specific for B. cenocepacia flagellin regardless 
of its glycosylation status. The MS spectrum of 
purified FliC from ΔBCAL0111 confirmed the 
loss of the glycan, as only a single molecular ion 
of 38,756.90 m/z corresponding to non-
glycosylated flagellin could be detected (Fig. 
2C). To confirm that BCAL0111 is required for 
FliC glycosylation, we placed BCAL0111 under 
the control of a rhamnose-inducible promoter 
(Fig. 5A). FliC purified from a culture in 
rhamnose-containing medium showed the same 
molecular weight in MS analysis and Coomassie 
staining as the parental strain. In contrast, 
flagellin isolated from a culture grown without 
rhamnose was present only in its non-
glycosylated state (Fig. 6, B-C). Hence, we 
concluded that BCAL0111 is the FliC 
glycosyltransferase and designated the gene as 
flmQ for flagellin modifying protein that 
transfers D-Qui4N(3OHBut). The deletion of 
BCAL0110 (vioA homolog) did not cause any 
detectable defect in FliC glycosylation (see 
below).  
 The B. cenocepacia K56-2 LPS contains O 
antigen. Glycans from the O antigen were 
detected in our sugar analyses. Therefore, we 
sought to delete the O-antigen genes to avoid 
this contamination. Repeated attempts to delete 
genes between wbiI (BCAL3119) and rmlB 
(BCAL3135; Fig. 5B (15)) failed (see also 
below). However, a deletion including wbiI and 
wzm (BCAL3131) was obtained and confirmed 
by PCR and SDS-PAGE analyses of LPS profile 
of the mutant strain (Fig. 7). Analyses of FliC in 
the ΔwbiI-wzm mutant showed the loss of the 
flagellin glycan (Fig. 6A). Thus, we concluded 
that FliC glycosylation requires one or more 
components of the O-antigen cluster. Genes in 
the O-antigen cluster that could be involved in 
the biosynthesis pathway of the FliC glycan are 
vioA (BCAL3129), a nucleotide sugar 
aminotransferase from dTDP-D-Qui4N 
biosynthesis pathway (48) and wbxC 
(BCAL3123), a putative acetyltransferase. No 
differences in flagellin glycosylation were 
detected in ΔBCAL3129 compared to the 
parental isolate (data not shown). Attempts to 
generate a single wbxC deletion failed, but it was 
possible to delete this gene together with the 
neighbouring glycosyltransferase wbxD 
(BCAL3124). While the single wbxD deletion 
did not affect FliC glycosylation (Fig. 2D), MS 
and SDS-PAGE analyses of ΔwbxCD revealed 
loss of glycosylation (Fig. 6D). Introducing a 
functional wbxC on a plasmid (pIN62/wbxC) 
into ΔwbxCD restored FliC glycosylation (Fig. 
6E). From these results we concluded that wbxC 
is involved in the biosynthesis of dTDP-D-
Qui4N(3HOBut), possibly by catalysing an 
acetyltransferase step prior to the formation of 
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the 3-hydroxybutyric acid side chain. This 
interpretation is consistent with the high degree 
of homology in the primary amino acid sequence 
of WbxC and the Acinetobacter baumannii 
WeeI protein, which is an acetyltransferase 
involved in the biosynthesis of UDP-N,N'-
diacetylbacillosamine (49,50). We did not 
succeed in any attempts to construct a double 
deletion mutant eliminating vioA (BCAL3129) 
and its putative homologue in the fliC region 
(BCAL0110) despite using the same mutagenic 
plasmids that were employed to delete both 
genes separately. However, it was possible to 
delete BCAL0110 in the ΔwbiI-wzm background 
and conversely, to delete the wbiI-wzm region in 
the ΔBCAL0110 strain. These results 
demonstrate that both vioA and its BCAL0110 
homologue are non-essential genes (Fig. 5). 
 We also investigated the conservation of the 
genetic organization of the fliC region in other 
Burkholderia species. A similar gene 
organization as in J2315, with a putative flmQ 
(BCAL0111) homologue placed downstream of 
fliCDT, was observed in B. pseudomallei, B. 
mallei, B. glumae, B. xenovorans, B. 
vietnamiensis and B. multivorans (Fig. 8A). B. 
thailandensis carries 11 additional genes 
inserted between the flmQ homologue and fliT 
(Fig. 8B). In all these clusters the putative flmQ 
was placed downstream from putative fliT and 
upstream from putative vioA gene, in each case a 
homologue of BCAL0110, and had no 
homologues elsewhere in the genome. In B. 
cepacia, the flagellin cluster has a unique 
organization (Fig. 8C), where fliT is followed by 
a gene encoding a glycosyltransferase 
(GEM_0145) and the flmQ homologue 
(GEM_0144), but in the reverse orientation. 
Also in B. cepacia, the only BCAL0110 
aminotransferase homologue (GEM_1565) is 
located outside of the flagellin cluster. Despite 
the variations among different species, the 
presence of homologous glycosyltransferase and 
aminotransferase genes in their flagellin clusters 
suggest that flagellin glycosylation is common 
in multiple species of the Burkholderia genus. 
Indeed, it was reported that B. pseudomallei and 
B. thailandensis produce glycosylated flagellin, 
but the glycan described in these strains is 
different than the one identified here (33). 
 RmlB is an Essential Gene in B. 
cenocepacia–RmlB (dTDP-D-glucose 4,6-
dehydratase), one of the enzymes encoded by 
the B. cenocepacia O-antigen cluster, is needed 
for the synthesis of dTDP-L-rhamnose, which in 
turn is required for the assembly of the O-
antigen repeating unit (15) (Fig. 5B). RmlB is 
also responsible for producing the precursor for 
biosynthesis of dTDP-D-Qui4N (51). In the 
course of these studies, we noticed that rmlB 
(BCAL3135) could not be deleted, suggesting 
the possibility that this gene is essential. To 
evaluate this notion, we constructed a 
conditional mutant by placing the rhamnose-
inducible promoter upstream from rmlB. All 
tested strains including the control strains 
XOA10 (Prha::BCAL1928; non-lethal 
conditional mutant) and XOA11 (Prha::arnT; 
lethal conditional mutant) (17) grew well when 
incubated on LB agar plates with rhamnose. In 
contrast, only XOA10 grew well in the absence 
of rhamnose whereas XOA11 and the Prha::rmlB 
strains grew very poorly (data not shown). The 
effect of rhamnose depletion was much more 
dramatic in liquid cultures (Fig. 9). The 
rhamnose inducible vector was also inserted 
upstream from rmlC (BCAL3133) and rmlD 
(BCAL3132), which are downstream from rmlB 
to examine their possible essentiality in B. 
cenocepacia, but rhamnose depletion did not 
cause any growth alteration in these strains (Fig. 
9). Because BCAS0105, a gene located in the 
third chromosome of B. cenocepacia, encodes a 
putative RmlD homologue rhamnose depletion 
experiments were also performed in a 
ΔBCAS0105 strain carrying Prha::rmlD. These 
experiments indicated that 
ΔBCAS0105/Prha::rmlD is viable under 
rhamnose free conditions (Fig. 9), ruling out the 
possibility that BCAS0105 might have supplied 
the function of rmlD when this gene was placed 
under the control of the rhamnose-inducible 
promoter. Together, these results provide 
experimental evidence that rmlB is essential in 
B. cenocepacia K56-2.  
 Role of FliC Glycosylation on Bacterial 
Motility and Biofilm Formation–In natural 
environments, flagella are bacterial motility 
organelles. To examine the influence of flagellin 
glycosylation on B. cenocepacia motility, we 
tested the motility of the deletion mutants on 
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soft agar by measuring the diameter of bacterial 
growth after 24 h incubation at 37°C. The strain 
RSF44, which lacks flagella (38), did not 
migrate from the inoculation spot providing a 
negative control. Strain ΔBCAL0111 lacking the 
putative D-Qui4N(3HOBut) transferase flmQ, 
showed a slight alteration in motility when 
compared to the parental isolate (Fig. 10A), 
while ΔwbxCD, missing the putative 
acetyltransferase and an O-antigen 
glycosyltransferase, had a much stronger effect 
on motility. The ΔwbiI-wzm mutant, which 
causes complete loss of O antigen and the FliC 
glycan led to ~ 50% decrease in motility. 
Therefore, we conclude from these results that 
flagellin glycosylation and a complete O antigen 
are required for normal motility of B. 
cenocepacia. Flagella also contribute to biofilm 
production. When compared with the parental 
strain, production of biofilm by ΔBCAL0111 
was at a similar level as the flagella lacking 
strain RSF44 (Fig. 10B), suggesting that the 
presence of glycosylation and not the flagella 
alone is required for normal biofilm formation.  
 FliC Glycosylation Reduces TLR5-mediated 
Responses–To examine the biological 
consequence of flagellin glycosylation in innate 
immune responses, human THP1 monocyte cells 
were stimulated with purified flagellins obtained 
from the parental strain (glycosylated FliC) and 
the ΔBCAL0111 mutant (non-glycosylated 
FliC). Stimulation of THP1 cells with both 
proteins resulted in production of the pro-
inflammatory cytokines IL-1β (Fig. 11A), TNF-
α (Fig. 11B) and IL-6 (Fig. 11C). However, non-
glycosylated FliC was significantly more 
efficacious than the glycosylated counterpart in 
inducing IL-1β, TNF-α and IL-6. To eliminate 
the possibility that LPS contamination in the 
flagellin preparations could confound these 
results, additional experiments were performed 
in HEK293 cells stably expressing TLR5 
(HEK293 cells normally lack Toll-like receptors 
(52,53)), which specifically recognizes flagellin. 
Again, the non-glycosylated FliC was more 
effective in inducing pro-inflammatory cytokine 
production in TLR5 cells as indicated by 
increased levels of IL-8 (Fig. 12A). We then 
looked at intracellular signalling and showed 
that non-glycosylated FliC is also more effective 
at activating NFκB (as measured by induction of 
a transfected NFκB-regulated luciferase reporter 
gene, Fig. 12B) and the phosphorylation of the 
NFκB subunit p65 (Fig. 12C). Also, non-
glycosylated FliC mediated stronger 
phosphorylation of p38 MAPK (Fig. 12D). 
Together, these studies consistently show that 
non-glycosylated FliC is more effective than the 
glycosylated protein to stimulate pro-
inflammatory signalling by TLR5.  
 
DISCUSSION 
 
 Despite the previously described roles for 
flagella in B. cenocepacia pathogenicity (25,26), 
this is the first report describing flagellin 
glycosylation in this bacterium and identifying 
the genes involved in the biosynthesis of the 
glycan. We showed that the B. cenocepacia 
flagellin is modified with a viosamine (Qui4N) 
derivative, D-Qui4N(3HOBut), on at least ten 
glycosylation sites within the protein. A sugar 
similar to D-Qui4N(3HOBut) but carrying an 
additional methyl group at C2 (54) was 
previously identified in glycosylated flagellin 
from P. syringae pv. tabaci (54,55), while 
Qui4N itself is a component of the flagellin 
glycan in P. aeruginosa PAK (56). The 
biosynthesis of dTDP-viosamine requires three 
enzymatic steps: (i) conversion of D-glucose-1-
phosphate into dTDP-D-glucose, catalyzed by 
RmlA; (ii) formation of dTDP-4-dehydro-6-
deoxy-D-glucose, catalyzed by RmlB; and (iii) 
an amination step catalyzed by the dTDP-4-
dehydro-6-deoxy-D-glucose aminotransferase 
encoded by the vioA gene (57,58). An additional 
step involves the acetylation of dTDP-viosamine 
to yield dTDP-N-acetylviosamine. Homologues 
of vioA and vioB, encoding the dTDP-viosamine 
acetyltransferase, have been identified in P. 
syringae pv. tabaci (54) and P. aeruginosa PAK 
(56), and both genes are required for the 
biosynthesis of the modified viosamine in P. 
syringae pv. tabaci. Despite that in B. 
cenocepacia there are two vioA homologues 
(BCAL0110 and BCAL3129), we could not 
identify a vioB homologue. Instead, we 
discovered that BCAL3123, encoding a putative 
acetyltransferase, is necessary for biosynthesis 
of D-Qui4N(3HOBut). Further experiments are 
necessary to provide evidence whether 
BCAL3123 encodes an enzyme catalyzing the 
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direct transfer of 3OHBut or if there are 
additional steps with BCAL3123 acting as an N-
acetyltransferase prior to the formation of the 
3OHBut side chain. 
 In particular, our results point to a complex 
link between O-antigen biosynthesis and the 
biosynthesis of the flagellin glycan. Two genes 
required for flagellin biosynthesis are located in 
the fliC gene cluster while the other genes are 
present in the O-antigen cluster. The flagellin 
gene cluster contains a vioA homolog that we 
show to be functionally redundant, and the flmQ 
glycosyltransferase gene, which is essential for 
FliC glycosylation. VioT, the flagellin 
glycosyltransferase in P. syringae pv. tabaci, has 
no homologues in B. cenocepacia and 
conversely, P. syringae pv. tabaci has no FlmQ 
homologues. Therefore, despite that both species 
use similar sugars for flagellin glycosylation, the 
specific glycosyltransferases involved are 
unique to each system, perhaps reflecting 
differences in the FliC acceptor protein in each 
species. Comparison of fliC biosynthesis clusters 
in other Burkholderia species indicated the 
presence of flmQ and vioA homologues just 
downstream from fliC, with only a few 
exceptions. Flagellins from B. pseudomallei and 
B. thailandensis were previously found to be 
glycosylated by a single glycan (33). Although 
the structures of the glycans are unknown their 
molecular masses are 291 Da and 342 Da for the 
B. pseudomallei and B. thailandensis, 
respectively, suggesting a different sugar than D-
Qui4N(3HOBut). Therefore, we conclude that 
despite a common fliC gene cluster organization 
in most Burkholderia species the glycan 
structure and glycosylation pattern of flagellin is 
likely species specific.  
 The discovery that rmlB is an essential gene 
in B. cenocepacia was unexpected. In a previous 
study, Juhas et al. (59) reported 84 candidate 
essential genes in B. cenocepacia that were not 
previously described as essential in any other 
bacteria. One of these genes was rmlD 
(BCAL3132), located within the O-antigen 
cluster, but these authors did not report any 
experimental verification of rmlD essentiality. In 
our study, we conclusively demonstrate that 
rmlB (BCAL3135), not rmlD, is essential for B. 
cenocepacia viability. The B. cenocepacia 
dTDP-L-rhamnose biosynthesis genes 
(rmlBACD) form one transcriptional unit with 
the first 10 genes of O-antigen cluster (15). 
RmlB is a dTDP-D-glucose 4,6-dehydratase and 
its function is required for the biosynthesis of 
nucleotide sugars like dTDP-D-fucose, dTDP-L-
rhamnose, dTDP-D-Qui4N and several other 
metabolites (48,51,60,61). In B. cenocepacia, 
rmlB is involved in the synthesis of O antigen, 
which contains rhamnose in its repeating unit 
(15), and in the synthesis of the D-
Qui4N(3HOBut) flagellin glycan, as we show 
here. However, O-antigen production and 
flagellin glycosylation are not required for B. 
cenocepacia viability. To our knowledge, RmlB 
has not been reported as an essential in other 
bacteria. The rlmB gene could not be deleted in 
B. thailandensis, but its deletion was possible in 
B. pseudomallei (33), suggesting it may be 
essential for at least another Burkholderia 
species. We speculate that the RmlB function 
may be required for the synthesis of another 
sugar nucleotide that may play an essential role 
in an as yet unidentified metabolic pathway, 
perhaps becoming a novel attractive candidate 
for antimicrobial development.  
 While the flagellum is important for 
bacterial motility, colonization and virulence 
(21,62,63), the functional role of glycosylation 
in host-bacteria interactions is less clear, and has 
only been investigated in a handful of bacterial 
species. For example, non-glycosylated flagellin 
mutants of the plant pathogen Pseudomonas 
syringae pv. tabaci are much less virulent on 
tobacco leaves than the wild-type strain 
(54,64,65). In contrast, lack of flagellin 
glycosylation does not affect the pathogenicity 
of starfruit pathogen P. syringae pv. averrhoi 
(66), while glycosylated flagellin of Acidovorax 
avenae elicits a strong immune response in 
cultured rice cells (67). 
 Contradictory results have also been 
reported for P. aeruginosa glycosylated 
flagellins in their ability to modulate innate 
immune responses in human epithelial cells 
(68,69). Two notorious human pathogens, 
Campylobacter jejuni and Helicobacter pylori, 
cannot assemble flagella without glycosylation 
and lack of flagella in both strains significantly 
reduces their virulence (70,71). It is also not 
clear whether flagellin glycosylation modulates 
TLR5 responses. The glycosylated flagellin 
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from C. jejuni is unique in that it fails to 
stimulate TLR5 (72). Reconstituting a functional 
TLR5 binding site in the C. jejuni flagellin 
resulted in the expression of glycosylated 
flagellin that induces a potent TLR5 response, 
ruling out a role for flagellin glycosylation in C. 
jejuni evasion of TLR5 detection (72). The 
elucidation of the flagellin glycosylation 
pathway in B. cenocepacia provided us with the 
opportunity to directly test the role of 
glycosylation in TLR5/flagellin-mediated 
inflammatory responses. We show that non-
glycosylated flagellin was more pro-
inflammatory than its fully glycosylated form. 
We also demonstrate that glycosylation of 
flagellin was associated with reduced efficacy 
with respect to stimulating TLR5-mediated 
signal transduction and gene expression. These 
results suggest that the presence of the glycan 
may alter to some extent flagellin detection by 
TLR5, although this was not directly examined 
here. We conclude that flagellin glycosylation 
could provide B. cenocepacia a strategy to 
reduce recognition by the innate immune 
system. However, further experiments are 
required to assess in vivo the role of flagellin 
glycosylation in the ability of these bacteria to 
cause chronic infection in cystic fibrosis 
patients. 	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TABLE 1. Strains and plasmids used in this study. 
Name Description Source 
Strains   
   
Burkholderia cenocepacia    
   
K56-2 ET12 clone related to J2315, cystic fibrosis clinical isolate BCRRC,1 (2,73) 
RSF44 K56-2, ΔfliCD (38) 
MH1K K56-2, ΔamrABC (BCAL1674–1676); Gms (74) 
ΔBCAL3119-3131 MH1K, ΔwbiI-wzm This study 
ΔBCAL3123-3124 MH1K, ΔwbxCD This study 
ΔBCAL0111 MH1K, ΔflmQ (flagellin glycan glycosyltransferase)  This study 
ΔBCAL0110 MH1K, ΔBCAL0110 (vioA paralog in the fliC gene cluster)  This study 
ΔBCAS0105 MH1K, ΔBCAS0105 (rmlD paralog in chromosome 3)   This study 
ΔBCAS0105 pSC200/rmlD  MH1K, ΔBCAS0105, containing Prha::rmlD  This study 
ΔBCAL3129 MH1K, ΔvioA This study 
XOA10 K56-2, Prha::BCAL1928 (17) 
XOA11 K56-2, Prha::arnT (17) 
MH43 MH1K, ΔwbxD (BCAL3124) M. Hamad 
MH1K pSC200/rmlD MH1K, Prha::rmlD  This study 
MH1K pSC200/rmlB MH1K, Prha::rmlB This study 
MH1K pSC200/rmlC MH1K, Prha::rmlC This study 
MH1K pSC200/BCAL0111 MH1K, Prha::BCAL0111 This study 
ΔBCAL3123-3124 pIN62/BCAL3123 MH1K, ΔwbxCD; wbxC+ This study 
   
E. coli    
   
GT115 
 
F- mcrA Δ(mrr-hsdRMS-mcrBC) ϕ80lacZΔM15 ΔlacX74 recA1 rpsL 
endA1 Δdcm uidA(ΔMluI)::pir-116 ΔsbcC-sbcD; used as donor strain 
Laboratory stock 
 
SY327 araD Δ(lac pro) argE(Am) recA56 nalA λ pir; Rifr; used as helper 
strain 
(75) 
   
Plasmids   
   
pRK2013 Helper plasmid used for bacterial conjugation; Kanr (76) 
pGPI-SceI-2 Suicide vector used for genetic manipulation of B. cenocepacia; Tpr (14) 
pDAI-SceI-SacB Replicative vector expressing I-SceI homing endonuclease; Tetr (74) 
pIN62 Broad host range replicative vector expressing DSRed, Cmr (40) 
pGPΩTp Suicide vector used for genetic manipulation of B. cenocepacia; Tpr (39) 
pSC200 Rhamnose inducible vector used for depletion experiments; Tpr (17) 
pGPI-SceI-2/BCAL3119-3131 Suicide vector used to delete O-antigen cluster  This study 
pGPI-SceI-2/BCAL3123-3124 Suicide vector used to delete wbxC and wbxD This study 
pGPI-SceI-2/BCAL0111 Suicide vector used to delete BCAL0111 This study 
pGPI-SceI-2/BCAL0110 Suicide vector used to delete BCAL0110  This study 
pGPI-SceI-2/BCAS0105 Suicide vector used to delete BCAS0105 This study 
pGPI-SceI-2/BCAL3129 Suicide vector used to delete vioA homologue in O-antigen cluster This study 
pGPΩTp/rmlD Vector used to create gene disruption in rmlD (BCAL3132) This study 
pSC200/rmlB Prha::rmlB (BCAL3135) This study 
pSC200/rmlC Prha::rmlC (BCAL3133) This study 
pSC200/rmlD Prha::rmlD (BCAL3132) This study 
pSC200/BCAL0111 Prha::BCAL0111 This study 
pIN62/BCAL3123 Vector used for complementation of wbxC (BCAL3123) This study 
 
1. BCRRC, B. cepacia Research and Referral Repository for Canadian CF Clinics; Cmr, chloramphenicol resistance; Tpr, trimethoprim resistance; 
Tetr, tetracycline resistance; Kanr, kanamycin resistance; DSRed, red fluorescent protein from Discosoma sp. 
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TABLE 2. Primers used in this study (restriction sites are italicized). 
Name Sequence (5’- 3’) Restriction site 
5235 gattgatgcggccgcgaagccgccatcggcgcgaacccg NotI 
5236 gcacctaagatctgccagcatgcgccgtcttgcggg BglII 
5237 tagctgagatctggcgcaatcggcaatgagggcgaccag BglII 
5238 aacgtgtctagaagtgtggtggtgtcgctgctgagc XbaI 
5685 cgtagtgaattcgacggcagcaagcaggcaccttattcgga EcoR1 
5686 atcatatctagaccggcacgccgttccgcgagggacttc XbaI 
5852 aatgaagatctcgccgccgtgccccatgctcgacgcctg BglII 
5853 catatgcggccgcctacaagcacgtgccgctgatggaag NotI 
5888 gatcgatgcggccgcacttgaaagacgatcattcccacg NotI 
5889 attgctctagacgttttgatgaacgtttcggact XbaI 
5922 gcacctaagatctctaccgaaggggcaggccggggctgtt BglII 
5923 gtagtcgcggccgccgagtcgaggacgtcgagttcggcg NotI 
5924 cagtactctagagtcgtcggacggggggatacggtggtc XbaI 
5925 gtagtcgcggccgcccgttacccgacctacacgcccgacgtc NotI 
6021 tagctacatatgatcctggttacgggcggcgcggg NdeI 
6022 taacgtctagagaacgtgccgaccacgttggtctggac XbaI 
6023 tagctgcatatgcgtgaggcaacgatgagctggaaaccg NdeI 
6024 atatgtctagacgagccgcgcgctgcggcaacgcgtgcc XbaI 
6093 cgggtgatccgggaagttctggatgaagacctggcggc n/a 
6094 aatgaacgagtgcttccgccgacgccaaaacggctttcc n/a 
6165 catagcggccgccttctgcccaccattcgtcaaccacgc NotI 
6166 cgactagatctatctaagcatcggtcaggtcgacacatg BglII 
6167 catagcggccgcaagcagttcaacgtattcgcgcgtcgc NotI 
6168 gtcatctagagctgagcgccgtgttgtatgcggcacatg XbaI 
Q38 tcatctagagctcgtcgatttgatcggtacgcgccatac XbaI 
Q39 ccttttgcggccgcaatgcccgtattgcgcgcgccagac NotI 
Q89 tagctgcatatgatgttctcgaccgaactgcccgccac NdeI 
Q90 taacgtctagaccgtttgcccggtgcgatgcagcg XbaI 
Q91 tagctacatatgatggccatccaagtaacggtgacagc NdeI 
Q92 taacgtctagatcgtccgacaggacaacccccacccac XbaI 
L3123 US BglII gactagatctccgtggccattcgtgccacaggcatcc BglII 
L3123 US NotI attagcggccgcatcgcgatgctctggcgagacgagcg NotI 
L0110 US XbaI agtcatctagattgcgtgcacgctgctcagcgtccgcgg XbaI 
L0110 US NotI catagcggccgcgcaagggtgccgttcgcgaacagcgac NotI 
L0110 DS NotI catagcggccgcgtcgcgaaccacgcgtatttcccgatc NotI 
L0110 DS BglII acgcgttcagatctttcgagttcgacaacagcgcgatgg BglII 
L3123 XbaI tagtcatctagattaggccgaccgtttcatcaatggcac XbaI 
L3123 NdeI acgctcatatggattggagtgaatgatggagcgaatcgc NdeI 
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TABLE 3. Peptide ions identified after combining MS/MS data from tryptic, chymotryptic and 
AspN/tryptic digests of B. cenocepacia FliC. Representative unmodified and modified ions are presented. 
Ions were confirmed in QTof and Orbitrap Elite analyses; (+231) refers to glycan modification 
[Qui4N(3HOBut)]; oxidation refers to methionine (+16 Da). 
 
Start-End  MW  Oxidation 
(+16) 
Sequence 
 Observed 
(m/z) 
Calculated Expected   
1 - 36 954.2421 3812.9393 3812.9915 yes MLGINSNINSLVAQQNLNGSQNALSQAITRLSSGKR 
37 - 52 773.3992 1544.7838 1544.7794 no INSAADDAAGLAISTR 
53 - 90 992.7329 3966.9025 3966.9011 yes (2 x) MQTQINGLNQGVSNANDGVSMIQTASSALSSLTNSLQR 
91 - 106 840.9565 1679.8984 1679.8512 yes IRQLAVQASTGTMSTT 
107 - 137 1154.2551 3459.7435 3459.7230 no DQAALQQEVSQQIQEVNRIASQTTYNGTNIL 
138 - 158 1010.5225 2019.0304 2019.0273 no DGSAGIVSFQVGANVGQTISL 
159 - 168 519.2255 1036.4364 1036.485 no DLSQSMSAAK 
159 - 168 527.2358 1052.4570 1052.4808 yes DLSQSMSAAK 
159 - 168 642.8051 1283.5956 1283.5677 yes DLSQSMSAAK (+231)* 
169 - 176 386.2400 770.4654 770.4650 no IGGGLVQK 
177 - 211 1118.2345 3351.6817 3351.6794 no GQTVGTVTGLSLDNNGAYTGSGATITAINVLSDGK 
177 - 211 1195.2588 3582.7546 3582.7663 no GQTVGTVTGLSLDNNGAYTGSGATITAINVLSDGK (+231) 
187 - 206 1085.5468 2169.0790 2169.0199 no SLDNNGAYTGSGATITAINV (+231) 
187 - 211 813.7294 2438.1664 2438.1925 no SLDNNGAYTGSGATITAINVLSDGK 
187 - 211 890.7588 2669.2546 2669.2794 no SLDNNGAYTGSGATITAINVLSDGK (+231) 
189 - 208 969.9615 1937.9084 1937.9330 no DNNGAYTGSGATITAINVLS 
189 - 208 724.0175 2169.0307 2169.0199 no DNNGAYTGSGATITAINVLS (+231) 
189 - 217 1032.8304 3095.4694 3095.4333 no DNNGAYTGSGATITAINVLSDGKGGYTFT (+231) 
212-233 904.7971 2709.2692 2709.2659 no GGYTFTDQNGGAISQTVAQSVF (2 x 231)# 
234 - 251 1055.0292 2108.0438 2108.0009 no GANATTGTGTAVGNLTLQ (2 x 231)* 
252 - 286 1258.6530 3772.9372 3772.9331 no SGATGAGTSAAQQTAITNAIAQINAVNKPATVSNL (2 x 231) 
287 - 321 1176.9285 3527.7637 3527.7637 yes DISTVSGANVAMVSIDNALQTVNNVQAALGAAQNR 
287 - 321 1253.9667 3758.8745 3758.8745 yes DISTVSGANVAMVSIDNALQTVNNVQAALGAAQNR (+231) 
290 - 321 1148.9210 3443.7412 3443.7076 yes TVSGANVAMVSIDNALQTVNNVQAALGAAQNR (+231) 
322 - 357 952.9465 3807.7569 3807.7381 yes FTAIATSQQAESTDLSSAQSQITDANFAQETANMSK 
359 - 382 849.4679 2545.3819 2545.4592 no QVLQQAGISVLAQANSLPQQVLKL 
371 - 384 790.4595 1578.9044 1578.9093 no QANSLPQQVLKLLQ 
 
* data obtained with QTof only 
# data obtained with Orbitrap Elite only 
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FIGURE 1. SDS-PAGE and Western blot analyses of B. cenocepacia FliC. A, Coomassie stained SDS-
PAGE showing crude flagellar filaments (C), supernatant obtained after insoluble flagella were 
sedimented at 16,000 xg for 10 min (S), and purified flagellin after solubilization with 8 M urea and 
desalting (P). B, Crude flagellar filaments from the B. cenocepacia parental strain (WT) and ΔBCAL0111 
(Δ0111) were analysed by Western blot with the AVIVA RFFL/ARP42986_P050 antibody. C, 
Coomassie-blue stained SDS-PAGE of crude flagellar filaments from B. cenocepacia parental strain 
(WT) and ΔBCAL0111 (Δ0111) from the same preparation used in panel B. D, Coomassie blue stained 
SDS-PAGE of chemically deglycosylated (dgWT) and native (WT) flagellin. Arrows indicate the 
corresponding molecular masses of the protein standards in kDa. 
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FIGURE 2. Mass spectra of purified flagellin preparations. A, B. cenocepacia flagellin. B, chemically 
deglycosylated flagellin. C, non-glycosylated flagellin purified from the ΔBCAL0111 mutant strain. D,  
flagellin purified from strain MH43 (ΔwbxD). Arrows indicate the difference of 231 m/z between ions. 
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FIGURE 3. Structure of the B. cenocepacia FliC glycan [4,6-dideoxy-4-(3-hydroxybutanoylamino)-D-
glucose, D-Qui4N(3HOBut)]. 
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FIGURE 4. GC/MS spectra after methanolysis and β-elimination of B. cenocepacia FliC glycan 
(K56-2) and control sample (O antigen of P. stuartii O43). A, the top two graphs correspond to an 
overview of entire spectra for P. stuartii O43 O antigen and B. cenocepacia K56-2 FliC samples. Qui4N 
peaks at 13.8 and 14.4 (representing α and β-configured derivatives) are indicated. Additional peaks 
detected in the O43 spectrum represent other sugars from the O antigen (44). Additional peaks in the FliC 
spectrum represent derivatized amino acids released from the FliC protein during methanolysis. The 
lower two spectra show the characteristic fragmentation pattern of ions at 13.8 min (fragmentation pattern 
of ion at 14.4 min was identical). M corresponds to molecular weight of derivatized Qui4N (303 Da). B, 
the top graph shows an overview of the GC spectrum of the glycan released from FliC during β-
elimination. Insert shows the derivatized glycan (461 Da) with the characteristic fragmentation pattern of 
the sugar and 3-hydroxy butyric acid. Lower graph shows the MS/MS fragmentation spectrum of the ion 
at 24.23 min. Differences between fragment ions (Δ) correspond to CH2CO (Δ42), CH3CHO (Δ44), 
CH3COO- (Δ59), and CH3COOH (Δ60). 
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FIGURE 5. Gene organization of the fliC region (A) and the O-antigen cluster (B) in B. cenocepacia. 
Deletion mutants are indicated by thick bars. Vertical arrows indicate insertion sites of the rhamnose 
inducible pSC200 vector. Genes showed as striped arrows encode the predicted enzymes required for 
FliC glycosylation. 
26	  
	  
 
 
FIGURE 6. Mass spectra of flagellin from various B. cenocepacia mutant strains. A, ΔBCAL3119-
3131; B, MH1K pSC200/BCAL0111 grown in the presence of rhamnose; C, MH1K pSC200/BCAL0111 
grown without rhamnose; D, ΔBCAL3123-3124; E, ΔBCAL3123-3124 pIN62/BCAL3123. Arrows 
indicate the ΔMW of 231 Da. 
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FIGURE 7. Silver stained 14% SDS-PAGE of whole cell lysates of B. cenocepacia. Whole cell lysates 
from B. cenocepacia mutants were analyzed in silver stained 14% SDS-PAGE. The strains used were: 
MH1K (lane 1), ΔBCAL3119-3131 (lane 2), ΔBCAL3129 (lane 3), ΔBCAL0110 (lane 4), ΔBCAL0111 
(lane 5), ΔBCAL3123-24 (lane 6), ΔBCAS0105 (lane 7), ΔBCAS0105 pGPΩTp/rmlD (lane 8), and 
MH1K pGPΩTp/rmlD (insertional mutant inactivating the last enzymatic step in dTDP-rhamnose 
biosynthesis; lane 9). Ladder-like bands (bracket) correspond to LPS containing lipid A-core covalently 
linked to O-antigen polysaccharides of varying length. Single bands in the low molecular weight region 
(arrow) correspond to lipid A-core molecules without O antigen.  
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FIGURE 8. Gene organization in fliC clusters of other Burkholderia species. The identity to flmQ is 
indicated in parenthesis. A, B. pseudomallei 668 (BURPS668; 49%), B. mallei NCTC 10247 
(BMA10247; 49%), B. glumae (bglu_1g; 47%), B. xenovorans LB400 (Bxe_A; 49%), B. multivorans 
CGD2 (BURMUCGD2; 80%), B. vietnamiensis AU4i (L810; 89%). B, B. thailandensis E264, dotted line 
represents eleven genes inserted between the putative fliT and flmQ (BCAL0111) homologues. C, B. 
cepacia GG4. Genes showed as striped arrows represent BCAL0111 (flmQ) homologue, and 
aminotransferase, a BCAL0110 homologue. GT, glycosyltransferase.  
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FIGURE 9. Conditional lethal phenotypes of B. cenocepacia strains. Strains were cultured in LB 
supplemented with 0.5% (wt/vol) rhamnose (A) or without rhamnose (B). After initial growth for 4 h 
(arrow), cultures were diluted 1:100 in fresh medium and incubated for 18 h.  
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FIGURE 10. Motility on soft LB agar plates (A) and biofilm formation (B) of B. cenocepacia strains. 
Data are representative of three independent experiments.	  Statistical analysis was performed by paired t-
test using two-tailed P-values. Significant differences in comparison with B. cenocepacia parental strain 
(WT) as control are indicated by ** (P < 0.01) or *** (P < 0.005). 
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FIGURE 11. Regulation of pro-inflammatory gene expression in THP1 cells by glycosylated and 
non-glycosylated forms of flagellin. THP1 cells were stimulated for 24 h in the absence (NT, non-
treated) or presence of varying concentrations of fully glycosylated wild type (WT) or non-glycosylated 
(Δ0111) forms of flagellin, purified from the B. cenocepacia parental or ΔBCAL0111 strains 
respectively.  Conditioned media were assayed for expression levels of (A) IL-1β, (B) TNF-α and (C) IL-
6. Data are representative of three independent experiments. Statistical analysis was performed by paired 
t-test using two-tailed P-values. Significant differences between samples from WT and Δ0111-treated 
cells are indicated by * (P<0.05), ** (P < 0.01) or *** (P < 0.001). 
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FIGURE 12. Differential stimulation of TLR5 signalling by glycosylated and non-glycosylated forms 
of flagellin. A, HEK293 cells, stably expressing TLR5 were stimulated for 24 h in the absence (NT, non-
treated) or presence of varying concentrations of fully glycosylated wild type (WT) or non-glycosylated 
(Δ0111) forms of flagellin purified from the B. cenocepacia parental or ΔBCAL0111 strains respectively.  
Conditioned medium was assayed for expression levels of IL-8. B, HEK293 cells, stably expressing 
TLR5, were transfected with a NFκB-regulated luciferase reporter gene and stimulated for 24 h as 
indicated above. Cell lysates were assayed for NFκB-regulated firefly luciferase activity and fold 
induction levels of NFκB-regulated luciferase are expressed relative to non-treated (NT) cells. Data are 
representative of three independent experiments. Statistical analysis was performed by paired t-test using 
two-tailed P-values. Significant differences between samples from WT and Δ0111-treated cells are 
indicated by * (P<0.05). HEK293 cells, stably expressing TLR5 were stimulated for indicated times with 
WT and Δ0111 flagellin (500 ng/ml). Cell lysates were immunoblotted for phosphorylated (p-) and total 
levels of p65 (C) and p38 (D), JNK and ERK MAP kinases. β-Actin was used as a loading control.    
 
